-
1 Comment
Biosynex SA is currently in a long term uptrend where the price is trading 24.3% above its 200 day moving average.
From a valuation standpoint, the stock is 98.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.5.
Based on the above factors, Biosynex SA gets an overall score of 2/5.
| ISIN | FR0011005933 |
|---|---|
| Sector | Healthcare |
| Industry | Medical Devices |
| Exchange | PA |
| CurrencyCode | EUR |
| PE Ratio | None |
|---|---|
| Target Price | 12.6 |
| Market Cap | 17M |
| Beta | 0.83 |
| Dividend Yield | None |
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention. It also provides thermometers, tensiometers, oximetry, hearing protection products, oral and dental hygiene products, self-tests, thermal pads, inhalation chambers, and thermotherapy products. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ALBIO.PA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
